Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ferdinando Varbella

Showing results (161-170 of 224) with videos related to

Pageof 23
Sort By:
JACC. Cardiovascular Interventions|December 9, 2017
The DELTA 2 Registry: A Multicenter Registry Evaluating Percutaneous Coronary Intervention With New-Generation Drug-Eluting Stents in Patients With Obstructive Left Main Coronary Artery DiseaseAlaide Chieffo, Akihito Tanaka, Gennaro Giustino, et al.
JACC. Cardiovascular Interventions|January 22, 2021
Unplanned Percutaneous Coronary Revascularization After TAVR: A Multicenter International RegistryGiulio G Stefanini, Enrico Cerrato, Carlo Andrea Pivato, et al.
The American Journal of Cardiology|March 30, 2022
Corrigendum to 'Long-Term (≥10 Years) Safety of Percutaneous Treatment of Unprotected Left Main Stenosis With Drug-Eluting Stents'[The American Journal of Cardiology 118 (2016) 32-39]Imad Sheiban, Claudio Moretti, Fabrizio D'Ascenzo, et al.
The American Journal of Cardiology|May 23, 2016
Long-Term (≥10 Years) Safety of Percutaneous Treatment of Unprotected Left Main Stenosis With Drug-Eluting StentsImad Sheiban, Claudio Moretti, Fabrizio D'Ascenzo, et al.
Open Heart|October 30, 2020
Angiographic control versus ischaemia-driven management of patients undergoing percutaneous revascularisation of the unprotected left main coronary artery with second-generation drug-eluting stents: rationale and design of the PULSE trialOvidio De Filippo, Matteo Bianco, Matteo Tebaldi, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|December 27, 2021
Predictors of fractional flow reserve/instantaneous wave-free ratio discordance: impact of tailored diagnostic cut-offs on clinical outcomes of deferred lesionsOvidio De Filippo, Guglielmo Gallone, Fabrizio D'Ascenzo, et al.
BMJ Open|September 8, 2017
APpropriAteness of percutaneous Coronary interventions in patients with ischaemic HEart disease in Italy: the APACHE pilot studySergio Leonardi, Marcello Marino, Gabriele Crimi, et al.
International Journal of Cardiology|January 1, 2019
New-generation drug-eluting stents for left main coronary artery disease according to the EXCEL trial enrollment criteria: Insights from the all-comers, international, multicenter DELTA-2 registryAkihito Tanaka, Gennaro Giustino, Ieva Briede, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|April 22, 2025
Impact of lesion hemodynamic pattern and calcium morphology on the functional efficacy of coronary intravascular lithotripsyLin Wang, Luca Paolucci, Angela McInerney, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|August 31, 2022
A large, prospective, multicentre study of left main PCI using a latest-generation zotarolimus-eluting stent: the ROLEX studyGiuseppe Tarantini, Luca Nai Fovino, Ferdinando Varbella, et al.
Pageof 23

Showing results (161-170 of 224) with videos related to

Sort By:
Pageof 23
JACC. Cardiovascular Interventions|December 9, 2017
The DELTA 2 Registry: A Multicenter Registry Evaluating Percutaneous Coronary Intervention With New-Generation Drug-Eluting Stents in Patients With Obstructive Left Main Coronary Artery DiseaseAlaide Chieffo, Akihito Tanaka, Gennaro Giustino, et al.
JACC. Cardiovascular Interventions|January 22, 2021
Unplanned Percutaneous Coronary Revascularization After TAVR: A Multicenter International RegistryGiulio G Stefanini, Enrico Cerrato, Carlo Andrea Pivato, et al.
The American Journal of Cardiology|March 30, 2022
Corrigendum to 'Long-Term (≥10 Years) Safety of Percutaneous Treatment of Unprotected Left Main Stenosis With Drug-Eluting Stents'[The American Journal of Cardiology 118 (2016) 32-39]Imad Sheiban, Claudio Moretti, Fabrizio D'Ascenzo, et al.
The American Journal of Cardiology|May 23, 2016
Long-Term (≥10 Years) Safety of Percutaneous Treatment of Unprotected Left Main Stenosis With Drug-Eluting StentsImad Sheiban, Claudio Moretti, Fabrizio D'Ascenzo, et al.
Open Heart|October 30, 2020
Angiographic control versus ischaemia-driven management of patients undergoing percutaneous revascularisation of the unprotected left main coronary artery with second-generation drug-eluting stents: rationale and design of the PULSE trialOvidio De Filippo, Matteo Bianco, Matteo Tebaldi, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|December 27, 2021
Predictors of fractional flow reserve/instantaneous wave-free ratio discordance: impact of tailored diagnostic cut-offs on clinical outcomes of deferred lesionsOvidio De Filippo, Guglielmo Gallone, Fabrizio D'Ascenzo, et al.
BMJ Open|September 8, 2017
APpropriAteness of percutaneous Coronary interventions in patients with ischaemic HEart disease in Italy: the APACHE pilot studySergio Leonardi, Marcello Marino, Gabriele Crimi, et al.
International Journal of Cardiology|January 1, 2019
New-generation drug-eluting stents for left main coronary artery disease according to the EXCEL trial enrollment criteria: Insights from the all-comers, international, multicenter DELTA-2 registryAkihito Tanaka, Gennaro Giustino, Ieva Briede, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|April 22, 2025
Impact of lesion hemodynamic pattern and calcium morphology on the functional efficacy of coronary intravascular lithotripsyLin Wang, Luca Paolucci, Angela McInerney, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|August 31, 2022
A large, prospective, multicentre study of left main PCI using a latest-generation zotarolimus-eluting stent: the ROLEX studyGiuseppe Tarantini, Luca Nai Fovino, Ferdinando Varbella, et al.
Pageof 23